XEL
55
5
T
36
4
CSX
43
2
SLB
44
-2
GPC
66
16
EXPD
45
2
CF
26
5
BLK
49
5
CHD
59
-2
WU
34
14
SYK
51
-6
DD
48
2
CSCO
53
2
BAC
44
2
HSY
41
3
AA
29
-2
CFG
30
-2
SJM
17
3
GIS
61
3
WEC
33
5
XEL
55
5
T
36
4
CSX
43
2
SLB
44
-2
GPC
66
16
EXPD
45
2
CF
26
5
BLK
49
5
CHD
59
-2
WU
34
14
SYK
51
-6
DD
48
2
CSCO
53
2
BAC
44
2
HSY
41
3
AA
29
-2
CFG
30
-2
SJM
17
3
GIS
61
3
WEC
33
5
Financhill
Back

CareTrust REIT 10K Form

Sell
44

CTRE
CareTrust REIT

Last Price:
23.73
Seasonality Move:
4.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTRE News And Ratings

See the #1 stock for the next 7 days that we like better than CTRE

CTRE Financial Statistics

Sales & Book Value

Annual Sales: $198.6M
Cash Flow: $40.83M
Price / Cash Flow: 17.52
Annual Sales: $10.90
Price / Book: 2.26

Profitability

EPS (TTM): 0.48000
Net Income (TTM): $53.74M
Gross Margin: $189.01M
Return on Equity: 5.34%
Return on Assets: 3.04%

CareTrust REIT Earnings Forecast

Key CareTrust REIT Financial Ratios

  • The Gross Profit Margin over the past 12 years for CTRE is 95.17%.
  • The Selling, General & Administrative Expenses for CTRE have been equal to 10.52% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 76.08% of Operating Income.
  • The Net Earning history of CTRE is 27.06% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 5 years.

CareTrust REIT Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care REITs
Sector: Real Estate
Current Symbol: CTRE
CUSIP: 14174T
Website: caretrustreit.com

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 4.39
Quick Ratio: 4.18

Price-to-Earnings

Trailing P/E Ratio: 47.48
Forward P/E Ratio: 20.12

CTRE Technical Analysis vs Fundamental Analysis

Sell
44
CareTrust REIT (CTRE) is a Sell

Is CareTrust REIT a Buy or a Sell?

  • CareTrust REIT stock is rated a Sell
    The current CareTrust REIT [CTRE] share price is $23.74. The Score for CTRE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.